key: cord-0763479-os62oshe
authors: Bairwa, Mukesh; Kumar, Rajesh; Ajmal, Mohammed; Bahurupi, Yogesh; Kant, Ravi
title: Predictors of critical illness and mortality based on symptoms and initial physical examination for patients with SARS-CoV-2: A retrospective cohort study
date: 2021-06-17
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2021.06.010
sha: c651f6839af56a94e64ac884f25854e5bf2825fb
doc_id: 763479
cord_uid: os62oshe

INTRODUCTION: An unidentified cluster of pneumonia was identified in Wuhan city of China in the last week of December 2019, named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2). The current study explored the predictors associated with critical illness and mortality based on symptoms at the time of admission and initial physical examination findings in patients with SARS-CoV-2. MATERIAL AND METHODS: A total of 249 records of laboratory-confirmed SARS-COV-2 patients were analyzed. Demographic profile and findings of initial physical examination were collected and analyzed. Bivariate logistic and multivariable stepwise forward regression analysis was used to identify the predictors of critical illness and mortality. RESULTS: A total of 249 records of SARS-COV-2 patients were retrospectively studied, of whom 66 (26.5%) developed a critical illness, and 58 (23.29%) died. The mean age of patients was 45.15 (16.34) years; 171 (68.71%) were men. From 27 potential predictors for developing a critical illness, 15 were reported independent predictors for critical illness, and 13 were for increased risk of mortality. Stepwise forward regression reported dyspnea as a single strongest predictor (OR, 5.800, 95% CI-2.724−12.346; p = 0.001, R(2) = 0.272) to develop critical illness. Likewise, the respiratory rate was alone reported as a strong predictor (OR, 1.381, 95% CI- 1.251−1.525; p = 0.000, R(2) = 0.329) for mortality. CONCLUSIONS: Coronavirus disease is a new challenge to the medical fraternity, leading to significant morbidity and mortality. Knowledge of potential risk factors could help clinicians assess patients' risk with unfavourable outcomes and improve hospitalization decisions in the early stage.

A cluster of unknown pneumonia cases was detected in the Wuhan city, Hubei province in China, in the last week of December 2019 [1] . After a month of the first coronavirus disease (COVID- 19) case, it was renamed as Acute Respiratory Syndrome Coronavirus -2 (SARS-Cov-2) [2] . The virus has rapidly spread worldwide and was declared an emergency of public health concern by the World Health Organisation on January 30, 2020 [3] .

The outbreak was reported from an enormous seafood market in China that also traded in live wild animals, and soon it became evident that person to person transmission is also possible [4] . The virus is highly infectious and is presumed to be transmitted through direct contact or droplet infection [5] , though some differences of opinion do exist [6] . The clinical manifestation of coronavirus disease appears to be vague, including asymptomatic infection to mild upper respiratory tract infection symptoms, acute viral pneumonia with severe respiratory symptoms to respiratory failure, and even death in many cases [7, 8] . However, clinical characteristics and outcomes among hospitalized patients with SARS-COV-2 have been variables across the globe [7, [9] [10] [11] . Earlier scientific work in a similar population reported increasing age [1, 8] , male sex [12, 13] , admission with coronary artery disease [1, 8] , pre-existing diabetes mellitus, hypertension, kidney disease, cerebral infarction, chronic obstructive pulmonary disease, cancer, and pancreatic problems shows a direct relation with poor outcomes and higher mortality in patients with COVID-19 [11, 14, 15] . Likewise, patients with multiple symptoms, more comorbidities, and advanced age had a higher risk than those without [12, 16] . The patients with advanced age have more number comorbidities, compromised lung capacity, deteriorated organ functions, and an impaired immune system, which is a well-known reason for developing critical illness; therefore, the clinicians should manage them with more attention considering high risk [12, 17] .

The determination of risk factors for critical illness development and possible mortality can play a vital role in decision making for clinicians. Further, it is vital to understand the clinical behavior of the disease in the progression and recovery phase in the local population. Here, we summarize the characteristics, associated risk factors, and outcomes of patients hospitalized to a tertiary care hospital, North India-with laboratory-confirmed SARS-COV-2, and their outcomes, either discharged or dead from April 14, 2020 to August 15, 2020.

The study was approved by the institutional ethics committee of All India Institute of Medical Sciences (AIIMS) Rishikesh (AIIMS/IEC/20/442); the need for written informed consent was deferred considering the use of anonymous record analysis. The probable and confirmed cases of SARS-COV-2 was established by using case definition as per WHO interim guidelines [18] . The records of laboratory-confirmed SARS-COV-2 patients hospitalized in a tertiary care public hospital, North India, were accessed from the medical record department (MRD). SARS-COV-2 diagnosis was confirmed by positive real-time reverse-transcription polymerase-chain reactions (RT-PCR) method using nasal and pharyngeal swab specimens. A team of experienced physicians in medicine studied, reviewed, and extracted the data using a pre-standardized validated checklist. A nursing expert has crosschecked each record independently for its accuracy and validation of the findings. A detailed checklist helped extract all relevant information of an individual patient on the following aspects; sociodemographic variables, clinical, and laboratory findings, including their symptomatology, discharge, or death status. Records of laboratory-confirmed SARS-COV-2 patients admitted during 4 months from April 15, 2020, to August 15, 2020, were studied in the present work.

We define the critical SARS-COV-2 (critical vs. non-critical) in line with the management guidelines issued by Govt. of India, Ministry of Health & Family Welfare (MoHFW), Directorate General of Health Services (DGHS) for clinicians taking care of hospitalized patients with COVID-19 [19] . These guidelines stated critical illness like fever or suspected respiratory infection, plus one of the three criteria; respiratory rate <30 breath/min, critical respiratory distress, and SpO2 < 90% at room air. Further, it stated that the cases with worsening respiratory symptoms within one week, those with bilateral opacities, not fully explained by effusions, lobar or lung collapse, or nodules in chest imagining (radiograph, CT scan, or lung ultrasound) are to be included in acute respiratory distress syndrome (ARDS) [19] . However, the present study excluded the findings of imaging modalities and other laboratory investigations.

Critical illness in the present work refers to a hospitalization composite to the intensive care unit (ICU), need of a ventilator, or mortality. These outcomes are very well explained as indicators of critical illness of SARS-COV-2 in earlier published work [20] [21] [22] .

Potential predictive variables included patient characteristics at hospitalization, socio-demographic variables, medical history, initial clinical signs and symptoms, imaging studies, and laboratory investigations. Demographic variables included age, gender, travel history, and smoking status. Details on medical history included comorbidity statuses such as hypertension, diabetes, chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), chronic kidney disease (CKD), and immunodeficiency diseases. Clinical symptoms included information on temperature, fever, heart rate, respiratory rate, systolic and diastolic blood pressure, abnormal cardiac rhythm, headache, nasal congestion, sore throat, expectoration, cough, fatigue, haemoptysis, dyspnoea, diarrhoea, nausea and vomiting, myalgia and arthralgia, and unconsciousness.

Records of all patients admitted with COVID-19 were reviewed retrospectively for information on socio-demographic variables, clinical findings, laboratory investigations, and possible outcomes. Two researchers independently reviewed the data and doublechecked the data extraction form to ensure the accuracy of information. The data collected was entered in to excel sheet and analyzed using SPSS Version 23 statistical software.

Statistical evaluation was done using descriptive statistics that included frequency and percentage for categorical variables and mean and standard deviation for continuous variables. The comparison was estimated using independent sample t-test and Chi-square or Fisher exact test as appropriate for continuous and categorical variables.

The univariate logistic regression method was used to explore the association of symptoms and initial physical examination findings with the development of critical illness and mortality in COVID-19 patients. Forward stepwise regression is applied to explore the predictors of critical illness and mortality in patients. P-value <0.05 (two-tailed) was considered significant for study.

Details on socio-demographic data, clinical presentation, and laboratory findings are summarized in Table 1 . In this study, each variable that displayed a significant difference at p < 0.05 between critical and non-critical patients were processed using bivariate analysis. In the cohort, we retrieved information from records of 249 patients admitted at a tertiary care hospital between April 15, 2020, to August 15, 2020. In the cohort, 26.5% of patients developed critical illness, and the rest were considered non-critical as per guidelines issued by Govt. of India, Ministry of Health & Family Welfare (MoHFW), Directorate General of Health Services (DGHS) [19] . Out of 58 patients, 34 (58.6%) died during hospitalization. The mean age of patients in the cohort was 45.15 (16.35) years; amongst these, 68.67% were males, and 31.33% were females. History of smoking either in the past or present was found in 18.18%; 34.54% had at least 1 existing comorbidity, including diabetes mellitus (19.68%), hypertension (9.68%), chronic obstructive pulmonary disease (12.45%), and coronary artery disease (7.23%). Fever (38.55%), dyspnea (32.1%), sore throat (7.23%), and productive cough (7.23%) were the common self-reported symptoms in patients at the time of presentation for physical examination. 44.98% of patients were febrile, and 26.51 % had a travel history to other parts of the country-a summary of the findings presented in Table 1 . Tables 2 and 3 depicts the association of initial symptoms and physical examination with developing critical illness and mortality among patients with SARS-COV-2. These findings depict that in the mortality cohort, patients were more advanced in age (difference, 3.07 years), had higher respiratory rate (difference, 1.28 breath/mints), higher heart rate (difference, 7.21), and reported slightly higher systolic and diastolic blood pressure.

27 variables were analyzed, including symptoms and initial physical examination of the patients to explore the predictors of critical illness and mortality. Chi-square and/or Fisher exact test and independent-sample t-test were used as appropriate for continuous and categorical variables to find the association of variables to the critical illness and death among SARS-COV-2 patients. Age, body temperature, heart rate, respiratory rate, current or former smoking status, presence of comorbidity, fever, cough, abnormal cardiac rhythm, dyspnea, sore throat, chronic kidney disease (CKD), coronary artery disease (CAD), hypertension (HTN), diabetes mellitus (DM), and chronic obstructive pulmonary disease (COPD), found a significant association (all p < 0.05) with development of critical illness in SARS-COV-2 patients ( Table 2) . Table 4 ).

The stepwise forward regression analysis was performed, entering all significant independent variables on bivariate analysis in a stepwise manner to analyze the prediction of the critical illness. Dyspnea was the single strongest predictor (OR, 5.800, 95% CI-2.724−12.346; P < 0.001) with a variance of 27.5% attributed to the critical illness (Nagelkerke r square = 0.272). Entering the uncon- Table 5 Multivariable Stepwise Regression to find the Predictors of Critical Illness (N = 249).

Step Predicators B OR (95% CI) Sig.

Step sciousness at the second step and dyspnea increases the chance to predict critical illness in 30.3% cases with a slight increase of 2.8% (Nagelkerke r square = 0.303) in variance. Further, combining the respiratory rate with dyspnea and unconsciousness at the third model would able to predict critical illness in 32.6% cases with a slight increase of prediction of 5.1 % chances from baseline (Nagelkerke r square = 0.326) ( Table 5) .

Further, findings show that age, body temperature, respiratory rate, heart rate, smoking status, presence of comorbidities, like chronic kidney disease, hypertension, and symptoms such as fever, cough, dyspnea, sore throat, and unconscious status, and partial pressure of oxygen (SpO2) in patients at the time of physical examination and screening were found to be significantly associated (all p < 0.05) with mortality ( Table 3) .

The variables were entered in to the bivariate logistic regression model and analysed out of these, 14 variables could independently predict mortality in SARS-COV-2 patients. These variables were, age (OR, 1.046; 95% CI, 1. Table 6 ).

The stepwise forward regression analysis was used to enter all significant variables to analyze the predictors of the risk of mortality in SARS-COV-2 patients. Respiratory rate alone was inserted Table 7 Multivariable stepwise regression to find the Predictors of Mortality (N = 249).

Predictors B OR (95 % CI) Sig.

Step (Table 7 ).

In this study, we explored the predictors of critical illness and mortality based on the symptoms at the time of admission and initial physical examination of SARS-COV-2 patients hospitalized at a tertiary care public hospital.

The typical clinical manifestations at the time of admission were fever, dry cough, dyspnea, sore throat, myalgia, headache, productive cough, and abnormal cardiac rate. However, a significant number of patients reported atypical symptoms initially, including nausea, vomiting, and diarrhea, which is closely similar to the earlier published work on characteristics of SARS-COV-2 patients [7, 23, 24] .

Risk factors related to critical illness and progression from critical illness to death included older age and comorbidity conditions, including hypertension, diabetes mellitus, coronary artery disease, chronic obstructive pulmonary disease, smoking status, raised body temperature, and unconscious status at the time of initial physical examination.

Also, we observed that several factors (e.g., comorbidities, hypertension, diabetes mellitus, febrile temperature, fever, cough, and dyspnea) associated with critical illness were more closely associated with death, which is consistent with the previous work that reported critical illness or higher death in patients with comor-bidities, hypertension and or diabetes [21, [24] [25] [26] . The effect of advanced age and comorbidities had been studied to the critical illness and addressed consistent findings in a similar cohort of patients with SARS-COV-2 [3, [27] [28] [29] .

Likewise, the impact of kidney disease and other respiratory problems on the critical illness and unfavorable outcomes in SARS-COV-2 patients agrees with the results noted in earlier studies in the same cohort population [7, 21, 23, 24, 30] . Data are scanty on the role of body temperature, fever, cough, and dyspnea on progression to critical illness and mortality and need further research in this direction to generalize the findings.

Considering comorbid conditions, fewer patients who died had comorbid conditions than those who developed a critical illness. Interestingly, the findings highlighted that advanced age might be at a higher risk of death, which is in line with the study's findings by Wang et al. [7] . These findings are further strengthened by evidence published in earlier work from China, which suggested that advanced age and existing comorbidities were associated with disease severity or higher mortality of SARS-COV-2 patients [7, 21, 23, 24, 26, 31] .

Current data suggests that several signs-symptoms were associated with developing critical illness in SARS-COV-2 patients (unconsciousness, fever, cough, abnormal cardiac rhythm, dyspnea, and sore throat). Interestingly, these factors were found to be associated with higher severity and worst outcome. However, abnormal cardiac rhythm pathogenesis could not be understood well concerning developing critical illness in the cohort. Risk factors studied matched with the earlier scientific work on SARS-COV-2, which suggested that fever, dyspnea, and unconsciousness were associated with increased illness severity [4, 30] . However, the findings on fever were negatively related to mortality in earlier work, which remains inconclusive and suggests the need for more research to reach an agreement [32] . However, the author advises interpreting these findings with caution due to potential bias and limitation of small sample size and need to be validated using double-blind, randomized controlled trials.

The presence of comorbidities, especially diabetes mellitus and hypertension, respiratory disease, and kidney diseases, was a decisive contribution to our patients' outcomes. The effect of comorbidities including diabetes mellitus, heart disease, and other comorbid conditions (hypertension, lung disease, and cerebrovascular disease) was independently associated with unfavorable outcomes (ICU admission, mechanical ventilation, and death) in SARS-COV-2 patients [3, 33] . However, this is not surprising; the role of heart diseases and /or diabetes mellitus is well studied and found to increase the poor or unfavorable outcomes, including death in a patient with community-acquired pneumonia in current and previous work as well [3, 8, 21, 26, 28] .

This record analysis should be appraised under many limitations. First, owing to only tertiary care public facilities in the region, only patients with critical illness were admitted during the coronavirus outbreak. Second, the study is limited to a single center with a small sample size. The study only considers findings on symptoms and clinical examination and excluded all laboratory and imaging work, which plays a critical role in decision making in the clinical setting and hence, may be considered preliminary in the area. A more extensive cohort study of patients with SARS-COV-2 from other regions or multicentre of the country would help reach a concrete conclusion on the predictors of critical illness and mortality in SARS-COV-2 patients.

In conclusion, we identified many risk factors for developing critical illness and mortality among SARS-COV-2 patients. This single-center retrospective analysis gives a new insight describing the impact of epidemiological and initial physical examination findings on developing critical illness and fatal outcomes in patients with COVID-19. Considering the unpredictable nature of the novel coronavirus and predicting frequent waves and long duration of the pandemic, it is urged to clinicians consider the symptoms and initial physical examination findings of SARS-COV-2 patients in clinical decision making. These determinants may find helpful for clinicians to identify the patients with fatal outcomes at an early stage.

No funding sources.

Indicators of critical illness and predictors of mortality in COVID-19 patients

Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group

Short-term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

Covid-19 mortality is negatively associated with test number and government effectiveness

Human immunopathogenesis of severe acute respiratory syndrome (SARS)

We have enough evidence, now it is time to act

Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore

Clinicodemographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India

Clinical outcomes among asymptomatic or mildly symptomatic COVID-19 patients in an isolation facility in Chennai, India

Age-related morbidity and mortality among patients with COVID-19

COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. medRxiv

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes

Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center

Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study

COVID-19 and older adults: what we know

Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance

Ministry of Health & Family Welfare Services. Directorate general of health division) (EMR)

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19

Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19

Corona health-care warriors in India: knowledge, attitude, and practices during COVID-19 outbreak

Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score

Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

A major outbreak of severe acute respiratory syndrome in Hong Kong

Clinical features and short-term outcomes of 144 patients with SARS in the greater toronto area

Coronavirus as a possible cause of severe acute respiratory syndrome

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

the National Heart and Blood Institute Acute Respiratory Distress Syndrome Network L. Body temperature and mortality in patients with acute respiratory distress syndrome

Clinical features and short-term outcomes of 102 patients with coronavirus disease

None declared.

Not required.